Targeting MERTK and AXL in <i>EGFR</i> Mutant Non-Small Cell Lung Cancer
MERTK and AXL are members of the TAM family of receptor tyrosine kinases and are abnormally expressed in 69% and 93% of non-small cell lung cancers (NSCLCs), respectively. Expression of MERTK and/or AXL provides a survival advantage for NSCLC cells and correlates with lymph node metastasis, drug res...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f008783afb8b4deca24ca6395ea261cc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|